基本分析
透過季節調整季營收，判斷美股整體趨勢，但注意股價有時候領先基本面的數據，應搭配其他領先指標判斷。
基本資料
個股的基本資料，以及所屬的類股和產業。
公司介紹
業務介紹
皇家製藥公司(Royalty Pharma plc)是一家在美國從事生物製藥權利金收購和創新融資的公司。它也參與各種生物製藥療法的權利金識別、評估和收購。此外,該公司與學術機構、研究醫院和非營利組織、小型和中型生物技術公司以及製藥公司的創新者進行合作。其投資組合包括約35種已上市療法和10種處於開發階段的產品候選藥物的權利金,涵蓋罕見疾病、癌症、神經系統疾病、傳染病、血液病和糖尿病等各種治療領域。該公司成立於1996年,總部位於紐約。
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
警語
1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整，需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。
